NCT06600269

Brief Summary

Effective walking and balance require not only lower limb muscle strength but also coordinated movement. For individuals with Spinocerebellar Ataxia (SCA), rehabilitation strategies targeting coordination are essential to improving mobility and reducing the burden on caregivers. However, evidence-based rehabilitation approaches for ataxia remain limited. Recent studies suggest that improvements in motor learning are often accompanied by changes in cortical excitability. Abnormal cortical excitability in SCA patients may hinder rehabilitation efforts, yet priming strategies-such as exercise or specific stimuli-have been shown to enhance motor learning by modulating cortical excitability. Cycling exercise, in particular, has demonstrated the potential to improve coordination and influence cortical plasticity in individuals with SCA, making it a promising priming strategy for coordination training. This clinical trial aims to:

  1. 1.Investigate the priming effect and neural mechanisms of acute cycling exercise on coordination training in patients with SCA.
  2. 2.Explore the long-term impact of priming cycling training on cortical plasticity and functional mobility in individuals with SCA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Oct 2024Aug 2026

First Submitted

Initial submission to the registry

September 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

October 4, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

October 8, 2024

Status Verified

October 1, 2024

Enrollment Period

1.8 years

First QC Date

September 13, 2024

Last Update Submit

October 4, 2024

Conditions

Keywords

Transcranial Magnetic Stimulation (TMS)GaitMotor ControlMotor Learning

Outcome Measures

Primary Outcomes (13)

  • Overall Response Time

    The sum of reaction time and movement time, providing a complete measure of the time taken from the stimulus presentation to the completion of the response. Unit: Second(s)

    Baseline, 2 weeks and 4 weeks

  • Overall Error Rate

    The total proportion of incorrect responses across a testing session or series of tasks.

    Baseline, 2 weeks and 4 weeks

  • Motor Evoked Potentials (MEPs)

    MEPs are the electrical responses recorded from muscles following stimulation of the motor cortex. They reflect the efficiency of neural transmission from the cortex to the muscle. Unit: millivolts (mV).

    Baseline, 2 weeks and 4 weeks

  • Intracortical Facilitation (ICF)

    ICF is measured by applying a pair of TMS pulses with a short interval (e.g., 8-15 ms) where the first (subthreshold) pulse is followed by a second (suprathreshold) pulse, leading to an increased amplitude of the MEP.

    Baseline, 2 weeks and 4 weeks

  • Intracortical Inhibition (ICI)

    ICI is measured similarly to ICF but with a shorter inter-stimulus interval (e.g., 1-5 ms), resulting in a suppressed MEP amplitude. This suppression reflects inhibitory processes within the cortex.

    Baseline, 2 weeks, and 4 weeks

  • Total Scale for the Assessment and Rating of Ataxia (SARA) Score

    To objectively assess ataxia severity across various domains of motor function including gait, stance, sitting, speech disturbance, finger chase, nose-finger test, fast alternating hand movements, and heel-shin slide. Each item is scored individually with a scale that typically ranges from 0 (no ataxia) to a maximum score that depends on the severity and the aspect of ataxia being assessed. The total score ranges from 0 (no ataxia) to 40 (most severe ataxia).

    Baseline, 2 weeks, and 4 weeks

  • Total Berg Balance Scale (BBS) Score

    To measure an individual's balance abilities through various tasks that mimic daily activities, assessing the risk of falls and overall balance proficiency. The BBS consists of 14 items that evaluate a range of functions including sitting to standing, standing unsupported, transferring, turning to look behind, picking up an object from the floor, and standing on one leg. Each task is rated on a scale from 0 (unable) to 4 (independent), with the total score ranging from 0 to 56. A higher total score indicates better balance and lower fall risk. Scores below 45 are generally indicative of increased fall risk.

    Baseline, 2 weeks, and 4 weeks

  • Total Time to Complete the Time Up and Go test (TUG test)

    The time, in seconds, it takes for a participant to complete the TUG test from the initial sitting position to returning to the seated position. An older adult who takes ≥12 seconds to complete the TUG is at risk for falling.

    Baseline, 2 weeks, and 4 weeks

  • Walking Speed

    The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s).

    Baseline, 2 weeks, and 4 weeks

  • Step Length

    The linear distance between the two ankles, typically expressed in centimeter(cm).

    Baseline, 2 weeks, and 4 weeks

  • Step Time

    The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds.

    Baseline, 2 weeks, and 4 weeks

  • Fatigue Level Measurement Using Multidimensional Fatigue Inventory (MFI)

    The MFI is a 20-item self-report questionnaire used to measure five dimensions of fatigue: general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation. Each dimension is scored separately, with higher scores indicating greater fatigue

    Baseline, 2 weeks, and 4 weeks

  • Sleep Quality Measurement Using Pittsburgh Sleep Quality Index (PSQI)

    The PSQI is a 19-item self-report questionnaire that assesses sleep quality over a 1-month period. It generates a global score ranging from 0 to 21, with higher scores indicating poorer sleep quality. The PSQI includes seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction.

    Baseline, 2 weeks, and 4 weeks

Secondary Outcomes (6)

  • Gait Speed Measurement Using 10-Meter Walk Test (10MWT)

    Baseline, 2 weeks, and 4 weeks

  • Double Support Time

    Baseline, 2 weeks, and 4 weeks

  • Single Support Time

    Baseline, 2 weeks, and 4 weeks

  • Swing Time

    Baseline, 2 weeks, and 4 weeks

  • Stance Time

    Baseline, 2 weeks, and 4 weeks

  • +1 more secondary outcomes

Study Arms (2)

SCA training group

EXPERIMENTAL

Long-term training

Procedure: Cycling Training

SCA Control group

NO INTERVENTION

Control group

Interventions

Cycling combined with priming strategies to enhance motor learning tasks. Each session will last for 15 minutes, conducted three times per week, over a period of two weeks.

SCA training group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Clinical diagnosis of SCA.

You may not qualify if:

  • Musculoskeletal injuries on legs
  • Osteoporosis.
  • Any peripheral or central nervous system injury or disease patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University

Taoyuan District, 333, Taiwan

RECRUITING

MeSH Terms

Conditions

Spinocerebellar Ataxias

Condition Hierarchy (Ancestors)

Cerebellar AtaxiaCerebellar DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesSpinocerebellar DegenerationsSpinal Cord DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesAtaxiaDyskinesiasNeurologic ManifestationsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 13, 2024

First Posted

September 19, 2024

Study Start

October 4, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

October 8, 2024

Record last verified: 2024-10

Locations